A lzheimer's disease (AD) is the leading cause of age-related neurodegeneration, affecting over 5.2 million people in the United States alone 1 . Our knowledge regarding mechanisms underlying the AD pathogenesis has greatly improved in the last decades, but still there is no cure 1 . Moreover, many unanswered questions have remained regarding the pathogenic cascade of AD, including reactive gliosis and the related neuronal damages [2] [3] [4] . Recent advances in cell reprograming allow the study of human neurons derived from AD patient fibroblasts [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] . These fibroblastderived neurons share the genetic material of AD patients and provide an excellent tool for recapitulating the pathogenic cascades of AD in human brain environment [10] [11] [12] [13] [14] . Indeed, familial and sporadic AD neurons derived from human induced pluripotent stem cells (iPSCs) exhibit relatively high levels of beta-amyloid 40 (Aβ 40) and phosphorylated tau (p-tau) compared to controls 14 . Furthermore, we previously reported a 3D culture model of AD using human neural progenitor cells overexpressing APP and PSEN1 with human familial AD (FAD) mutations 15, 16 . When seeded in a novel 3D culture system, these cells demonstrated robust extracellular aggregates of Aβ (Aβ -plaque-like) and Aβ -induced pathological tau aggregation (NFT-like) [15] [16] [17] [18] . While this 3D model successfully recapitulated key pathological hallmarks of AD, it did not contain a neuroinflammatory component, which is the essential pathological event observed in human AD patients and AD mouse models.
A lzheimer's disease (AD) is the leading cause of age-related neurodegeneration, affecting over 5.2 million people in the United States alone 1 . Our knowledge regarding mechanisms underlying the AD pathogenesis has greatly improved in the last decades, but still there is no cure 1 . Moreover, many unanswered questions have remained regarding the pathogenic cascade of AD, including reactive gliosis and the related neuronal damages [2] [3] [4] . Recent advances in cell reprograming allow the study of human neurons derived from AD patient fibroblasts [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] . These fibroblastderived neurons share the genetic material of AD patients and provide an excellent tool for recapitulating the pathogenic cascades of AD in human brain environment [10] [11] [12] [13] [14] . Indeed, familial and sporadic AD neurons derived from human induced pluripotent stem cells (iPSCs) exhibit relatively high levels of beta-amyloid 40 (Aβ 40) and phosphorylated tau (p-tau) compared to controls 14 . Furthermore, we previously reported a 3D culture model of AD using human neural progenitor cells overexpressing APP and PSEN1 with human familial AD (FAD) mutations 15, 16 . When seeded in a novel 3D culture system, these cells demonstrated robust extracellular aggregates of Aβ (Aβ -plaque-like) and Aβ -induced pathological tau aggregation (NFT-like) [15] [16] [17] [18] . While this 3D model successfully recapitulated key pathological hallmarks of AD, it did not contain a neuroinflammatory component, which is the essential pathological event observed in human AD patients and AD mouse models.
The next challenge is the generation of a human AD culture model that includes neuroinflammation, a key component of neurodegenerative disorders commonly induced through activation of microglia and astrocytes. The sustained activation of microglia results in a chronic neuroinflammatory response and increased production of proinflammatory cytokines, such as TNF-α and IL-1β 19 . Of relevance, recent genome-wide association studies have uncovered several risk-associated genes in the development of sporadic AD. Most of these risk genes are either expressed by microglia or associated with their reactivity, including CD33 20 , BIN1 21 , CR1 22 , TREM2 23 , and CLU 24 . As such, there is a pressing need for the development of organotypic models to detail cellular mechanisms and recapitulate the complex neural-glial interactions in AD.
Here we present an engineered model of neuron (Neu)+ astrocyte (AC) + microglia (MG) interaction in AD environment (Neu+ AC+ MG AD) that enables the study of human microglia recruitment, neuroinflammatory response, and damage to neurons and/or astrocytes (neurons/astrocytes). To achieve this, we built a human triculture system in which neurons and astrocytes differentiated first, and then added adult microglia cells at different stages of AD. This new 3D human AD triculture system demonstrated Aβ aggregation and p-tau formation along with increased chemokines and cytokines, including CCL2, IL8, TNF-α , and IFN-γ . Notably, 3D Neu+ AC AD culture induced microglia recruitment and led to marked neuron/astrocyte loss. Together, these results suggest that our new 3D human AD triculture system provides a valid model for investigating complex neuroinflammatory molecular mechanisms underlying AD pathology and may contribute to finding new therapeutic targets. , and microglia (red) with nuclear staining (white). Scale bars, 100 μ m in f; 40 μ m in g. h, Immunofluorescent microphotographs validate the differentiated neurons (blue, nucleus) with class III β -tubulin Tuj1 (red) and MAP2 (green), astrocytes (blue, nucleus) with S100 (red) and GFAP (yellow), and the recruited microglia (blue, nucleus; red, prestained membrane) with CD68 (yellow). Scale bars, 40 μ m for Tuj1 and MAP2; 20 μ m for S100, GFAP, and CD68. i-k, Western blot assay demonstrates the increased expression of neuronal markers (Tuj1: t = 9.105, df = 5.24, R 2 = 0.9405, F = 41.68, P = 0.0009, n = 20 devices from 3-week 1:1 thick-culture condition; MAP2: t = 25.64, df = 7.526, R 2 = 0.9887, F = 1.67, P = 0.0027, n = 20 devices from 3-week 1:1 thick-culture condition) and astrocyte markers (GFAP: t = 12.58, df = 7.828, R 2 = 0.9529, F = 1.349, P = 0.0019, n = 20 devices from 3-week 1:1 thick-culture condition) of the 3D culture system compared to a 2D culture after 3 weeks of differentiation. Data are normalized to undifferentiated hNPCs. All experiments were repeated ≥ 3 times statistics represent unpaired, two-sided Student's t tests; **P < 0.01. l, Time-lapse microphotographs show calcium signaling with Cal590 fluorescent dyes from firing neurons (top; orange triangle) and are compared with immunostained neuronal marker of Tuj1 in yellow and membrane in green (bottom). Scale bar, 50 μ m. m, Normalized values (Δ F/F) from neurons representative for control and for the AD model after 3 weeks of differentiation indicate functionally connected neuronal activities. All experiments were repeated ≥ 3 times; all parameters are presented as mean ± s.e.m.
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NATure NeurOscIeNce progenitor cells (ReNcell VM cells, an immortalized human neural progenitor cell line; hereafter referred to as hNPCs) that produce high levels of Aβ were developed through overexpression of a variant of the human Aβ precursor protein (APP) containing FAD mutations with both K670N/M671L (Swedish) and V717I (London) FAD mutations (APPSL) under the human cytomegalovirus immediate-early enhancer and promoter, as previously published ( Supplementary  Fig. 1 ) 15 . These transduced cells with control-GFP (Neu+ AC) or APPSL-GFP (Neu+ AC AD) lentiviral particles were enriched on the basis of GFP signals through fluorescence-activated cell sorting. Representative fluorescence microphotographs of differentiated ReN cells showed stable expression for more than 3 weeks (control-GFP: Neu + AC and APPSL-GFP: Neu + AC AD; Supplementary Fig. 1 ). The central and angular chambers were linked by migration channels (10 × 50 × 500 μ m, height × width × length) forming gradients of soluble factors. These long, thin migration channels prevented inadvertent entrance of inactivated microglia through mechanical constraints. Using this platform, we observed the migration of microglial cells, at single-cell resolution, in real time for extended periods (Fig. 1d) . hNPCs, differentiated into neuron and astrocyte, were successfully tricultured with adult microglia (Fig. 1d-g ). These observations demonstrated that our 3D microfluidic device enabled the formation of physiologically relevant human brain tissue-mimetic 3D structures ( Supplementary Fig. 2 ).
To demonstrate hNPCs differentiation in 3D cultures (Supplementary Videos 1 and 2), fixed cells were analyzed by immunofluorescence for the presence of neuronal/astrocyte markers. As previously reported, hNPCs robustly expressed class III beta-tubulin (Tuj1), microtubule-associated protein 2 (MAP2), glial fibrillary acidic protein (GFAP), and calcium-binding proteins (S100, S100A6, and S100β ) in week 3 ( Fig. 1h and Supplementary Figs. 3 and 4) 15 . Activated microglia, as demonstrated by CD68 expression, were also observed in triculture conditions in the 3D Neu+ AC+ MG AD culture model (Fig. 1h) . Neuronal (Tuj1, MAP2) and glial (GFAP) markers in undifferentiated and 3-week differentiated AD hNPCs were quantified by western blot analysis (Fig. 1i-k) . Western blot analysis for neuronal markers Tuj1 and MAP2, and for the astrocytic marker GFAP, demonstrated that neuronal and astrocyte differentiation of NPCs was significantly promoted, by 2.1-fold, 2.9-fold, and 2.3-fold, respectively, in 3D culture in microfluidic devices compared to 2D cultures. These differences may reflect the ability of 3D environments to promote differentiation and/or maturation of neural progenitor cells providing a high surface area for growth 25, 26 . We next characterized action potential-evoked calcium dynamics in individual neurons (Fig. 1l ) filled with Cal-590 27 . The recorded individual neurons were immunoassayed with the neuronal marker Tuj1 to confirm that the calcium dynamics was from neurons. High-magnification microphotographs of the soma of stained neurons displayed the characteristic ring shape arising from a lower fluorescence level in the nucleus compared with the surrounding cytoplasm ( Supplementary Fig. 5 ). We analyzed the spontaneous activity of these neurons by combining calcium activation, neuronal markers, and fast time-lapse imaging (50 frames per unit time) and found that calcium transients evoked by individual action potentials were discernible with a good signal-to-noise ratio ( Fig. 1m and Supplementary Video 3) 27 . Notably, 3D Neu+ AC AD showed a substantial increase of neuronal activity levels that could be observed when compared with week-matched control (3D Neu+ AC) in the 3-week-old cells. Furthermore, the fraction of neurons that were hyperactive (> 6 transients per 60 s) was markedly larger in 9-weekold 3D Neu+ AC AD than in 3-week-old 3D Neu+ AC AD, while the fraction of silent neurons (0 transients per 30 s) was not different between 3D Neu+ AC AD at week 3 and week 9 ( Supplementary Fig. 6 and Supplementary Videos 4 and 5). Taken together, these data clearly demonstrate the generation of functional neuron/astrocyte cell models in our 3D microfluidic culture system. (Fig. 2a,b) at week 3. Furthermore, at week 9, 3D Neu + AC AD was associated with significantly higher accumulations of Aβ 40 (78-fold and 2.8-fold compared to levels observed in 3D Neu + AC and 2D Neu + AC AD, respectively). Notably, the soluble Aβ 42 week 9/week 0 ratio in 3D Neu + AC AD was substantially decreased (≈ 20%), indicating that the 3D culture conditions may increase the aggregation of Aβ 42 (Fig. 2a,b and Supplementary  Figs. 7 and 8 ). This observation was further validated through western blot analysis of the various forms of aggregated Aβ in whole lysates (Fig. 2c,d) , with increased aggregated forms of Aβ found in 3D Neu + AC AD 28 . These observations are consistent with an accelerated Aβ accumulation due to limited diffusion in 3D culture conditions and diffusion of AD neuron-derived Aβ into the media in 2D cultures as previously reported 15, 16 . To determine whether our 3D Neu + AC AD secretes CCL2 (MCP-1), a chemokine upregulated in AD brains, we compared the level of CCL2 in various stages of the AD culture models 29 . We found that 3D Neu + AC AD (1,800 pg/mL) showed 2.9-fold and 1.3-fold more CCL2 secretion in conditioned media compared to 3D Neu + AC (620 pg/mL) and 2D Neu + AC AD (1,384 pg/mL), respectively (Fig. 2e) . To further explore pathology development in 3D cultured AD neurons/astrocytes, chemokine and cytokine secretion by 3D Neu + AC, 2D Neu + AC AD, and 3D Neu + AC AD cells was determined. First, we evaluated TNF-α levels in the culture medium and found TNF-α levels increased by 2.8-fold and 8.2-fold in week 6 (61 pg/mL) and week 9 (180 pg/mL), respectively, in 3D Neu + AC AD (Fig. 2f) , while moderate increases were observed in 2D Neu + AC AD. Unexpectedly, IFN-γ was exclusively secreted by 3D Neu + AC AD cells (9.2 pg/mL) but not detected in the other conditions tested (Fig. 2g) .
Regarding tau alterations 30 , Enzyme-linked immunosorbent assay (ELISA) of soluble p-tau (pSer231 tau; phosphorylated at Serine 231) in 3D Neu + AC AD cells showed that pSer231 tau levels increased by 2.2-fold and 5.1-fold at weeks 6 (271 pg/mL) and 9 (630 pg/mL), respectively, compared to 3D Neu + AC (Fig. 2h) . The presence of p-tau phosphorylation at Ser396 and Ser404 and at Ser202 and Thr206 was also confirmed by immunofluorescent staining using the p-tau antibodies PHF-1 and AT8, respectively, in both neuritic and soma bodies of 3D Neu+ AC AD cells ( Fig. 2i and Supplementary Fig. 9 ). 3D Neu+AC AD model induced microglial migration, phenotype changes, and secretion of pro-inflammatory factors. To test the hypothesis that neurons/astrocytes in AD environments induce activation and/or recruitment of microglial cells, we plated microglial cells in the angular chamber at day 0 of week 3, week 6, and week 9. To characterize the migration and phenotype changes of microglia, individual microglial cells were monitored for 7 d using time-lapse imaging microscopy ( Fig. 3a) . In the first 24 h, microglia in the angular chamber showed widely branched filopodia in all directions, a morphology typically associated with 'resting' microglia. Furthermore, most of the cells remained stationary during that period. Morphological changes and microglial migration toward the central chamber seeded with 3D Neu + AC AD was observed 48 h after cell seeding (Fig. 3b) . As determined by image analysis, microglial cells became elongated, with substantially increased cell length and microglial cell body area (Fig. 3b,c) . Furthermore, exposure of microglia to 3D Neu + AC AD induced upregulation Articles NATure NeurOscIeNce of microglial activation markers such as CD11b (Fig. 3d) . The migration rate of microglial cells in the 3D Neu + AC + MG AD environment was substantially higher compared with those in the other conditions tested, 3D Neu + AC + MG or 2D Neu + AC + MG AD. The microglial recruitment index ( Supplementary Fig. 10 ) was 8.1 ± 0.78% in 3D Neu + AC + MG AD cells compared with 4.2 ± 2.3% in 2D Neu + AC + MG AD cells and 0.9 ± 1.2% in 3D Neu + AC + MG cells (Fig. 3e) . Notably, neutralization of CCL2 chemokine signaling using an antibody against CCL2 reduced the ability of microglia to migrate in response to Neu + AC AD coculture conditions ( Supplementary Fig. 11 ). Other factors, such as ATP 31 ( Supplementary Fig. 12 ), may also contribute to microglial recruitment in our system. Notably, in the 3D Neu + AC + MG AD model, the aged cultures (week 9) led to the recruitment of more microglia cells as compared to early-stage cultures. 3D Neu + AC + MG AD and 2D Neu + AC + MG AD culture platforms had comparable effects on maximal microglial migration speed (5.0 ± 0.91 vs. 4. 3 ± 0.81; data not shown). The observed speed of migration (μ m/h) was similar to that previously observed in AD environments with soluble and bound Aβ conditions 15 . Next, we set out to identify the cytokines and chemokines that regulate the microglial migration and activation in our 3D AD . All experiments were repeated ≥ 3 times. e, Triculture in the 3D Neu + AC + MG AD model (red) leads to a dramatic increase in microglia recruitment, as measured by the total number of microglia accumulated in the central chamber compared to the 3D Neu + AC + MG control (blue) and the 2D Neu + AC + MG AD model (purple; R 2 = 0.9745, F 2,12 = 228.9; unpaired, two-way ANOVA, n = 5 devices per culture condition). All experiments were repeated ≥ 3 times. RI, microglial recruitment index. f,g, The 3D Neu + AC + MG AD also produced discernible amounts of (f) chemokines and (g) pro-inflammatory soluble factors (F 7,21 = 115.6; two-way ANOVA, n = 4 devices per culture condition). All experiments were repeated ≥ 3 times. **P < 0.001, ***P < 0.0001; *, not detected; n = 5 devices in a,e-g and n = 100 cells each in b-d. All data are presented as mean ± s.e.m.
Articles NATure NeurOscIeNce models. For this purpose, we first measured the secreted cytokine and chemokine levels in 3D Neu + AC and 3D Neu + AC AD models without microglial cells. Conditioned cell culture media were collected from the week 9 models and levels of 36 cytokines were analyzed. Notably, protein levels of CCL2, CXCL10, and CX3CL1 were substantially increased in 3D Neu + AC AD compared to the control 3D Neu + AC model (Fig. 3f) . In contrast, no changes in CCL3/4, CCL5, and CXCL1 expression were found in either culture model. Next, we assessed how inflammatory signaling was impacted by adding microglial cells to the 3D Neu + AC AD model. AD-related neuroinflammatory responses, such as chemokine release (Fig. 3f) and pro-inflammatory factor secretion ( Fig. 3g and Supplementary  Fig. 13 ), were generally increased by the addition of microglial cells. Indeed, IL-6, IL-8, and TNF-α concentrations were elevated by 2.2-, 2.7-, and 1.3-fold, respectively, compared to 3D Neu + AC AD alone. In addition, activated microglia induced the release of multiple chemokines including CCL2 (2.1-fold), CCL5 (26-fold), CXCL10 (2.6-fold), and CXCL12 (1.2-fold) in 3D Neu + AC + MG AD compared to the 3D Neu + AC AD. We also observed production of the leukocyte growth factors GM-CSF and G-CSF, which typically are not produced by neurons. MIF and PAI-1, important biomarkers of tau hyperphosphorylation in late-stage AD mouse model, were greatly increased in 3D Neu + AC + MG AD (Fig. 3g) 
31
. Secretion of inflammtory cytokines such as IL-1β and IL-17 and anti-inflammatory markers such as IL-1RA, IL-10, and TGF-β was very limited or below detectable levels. These data suggest that microglia elicit broad inflammatory signaling in response to our 3D Neu + AC AD model.
Recruited microglia are toxic to AD neurons and astrocytes. Next, we assessed the extent of cellular damage mediated by microglia in our 3D Neu + AC + MG AD culture model. On day 2, after adding microglial cells to 9-week-differentiated 3D Neu + AC AD system, we observed morphological changes of microglial cells co-localized with GFP + 3D Neu + AC AD cells ( Fig. 4a and Supplementary Video 6). After day 4, we observed slight decreases in neuron/ astrocyte surface area, including cell body and axon, when co-localized with microglia (Fig. 4a) . Axonal damages were also observed with co-localized microglial cells (Fig. 4b, Supplementary Fig. 14 , and Supplementary Video 7). Time-lapse imaging also indicated that AD neurons underwent changes in cell morphology, including retraction of the neurites toward the main cell bodies (Fig. 4c  and Supplementary Video 8) . To quantitatively analyze the cellular damages, we next performed image analysis by converting nucleusstained images into a dimension matrix to determine nucleus density in triculture conditions with microglia via heat map contours ( Fig. 4d and Supplementary Fig. 15 ). At day 2, cells exhibited relatively moderate density across regions of interest (ROIs). However, at day 6, a marked decrease of cellular density was observed around nearby microglia cells (Fig. 4e) . Indeed, after day 6 of triculture with microglial cells, there was a 21% reduction in Neu + AC survival counted by nucleus (Fig. 4e) and a marked reduction of about 37% in Neu + AC surface area (Fig. 4f) when tricultured with microglia compared to 9-week-old 3D Neu + AC AD only ( Supplementary  Fig. 15 ). To elucidate and quantify how microglia influence the induction of neuronal and/or astrocyte loss, we analyzed 9-weekold 3D Neu + AC + MG AD at day 2 and day 6 after microglial cell recruitment using immunostaining and immunoblotting to compare and quantify the loss of each cell type (Fig. 4g,h ). TUJ1 and MAP2 (neurons) and ALDH1L1 (astrocyte) markers were used to quantify the neuron and astrocyte loss. Our data indicated broad losses of neurons (Tuj1, 35.5%; MAP2, 27.9%) and astrocytes (15.7%) across all 3D Neu + AC + MG AD models tested, whereas the number of microglia (CD68 + ) remained the same (Fig. 5e) . Our results, therefore, suggest that the addition of microglial cells promotes distinct changes in the number and morphology of neurons/astrocytes, which is consistent with the neuropathological findings previously demonstrated in the 5xfAD mouse model 32 .
Recruited microglia induced neuronal loss through a IFN-γ-and TLR4-dependent mechanism. To test whether cytokines and chemokines contribute to neuron and astrocyte loss, we evaluated the contribution of IFN-γ and TLR4 on the production of neurotoxic mediators in our triculture system (Fig. 5a ). TNF-α and NO concentrations were measured in the presence of either neutralizing or blocking antibodies to IFN-γ or TLR4, respectively 33 . Recruited microglia in the 3D Neu + AC + MG AD model exhibited a 2.3-fold increase in TNF-α concentrations compared to the 3D Neu + AC AD model without microglia (Fig. 5b) . NO levels were also increased by 9.1-fold in the 3D Neu + AC + MG AD model, while not detectable in the 2D Neu + AC + MG AD model, possibly due to lack of IFN-γ in this system (Figs. 2g and 5c ). Addition of either TLR4-or IFN-γ -neutralizing antibodies reduced TNF-α and NO concentrations, demonstrating that the neuron/astrocyte loss in 3D Neu + AC + MG AD is dependent on microglial activation. We also measured lactate dehydrogenase (LDH) release in conditioned media as a biochemical marker of cell death (Fig. 5d) . Notably, incubation with the TLR4 antagonist LPS-RS substantially decreased LDH levels in the 3D Neu + AC + MG AD culture model (Fig. 5d ). These data suggest that the microglia-induced neuronal loss in the 3D Neu + AC + MG AD model occurs at least partially via IFN-γ -and TLR4-dependent mechanisms, in agreement with the other models 33 .
We also observed increased GFAP signals and altered astrocyte morphology in the 3D Neu + AC AD and Neu + AC + MG AD models, suggestive of astrogliosis (Fig. 5e ). Both 3D Neu + AC AD and Neu + AC + MG AD models induced astrogliosis in week 9, as indicated by increased GFAP expression. Furthermore, astrocyte activation was concomitant with activation of microglia, as indicated by increases in CD68 immunoreactivity and thickening of their processes, indicative of a shift in state toward a more activated amoeboid morphology (Fig. 5e) . Additionally, we observed that some of the neuronal loss was associated with the activation of apoptotic pathways, as we observed fragmented nuclei after 8 h in 3D Neu + AC + MG AD (Fig. 5f ).
Knocking down TLR4 expression provided protection against neurotoxic microglial activation. Since we observed a reduction in TNF-α and NO concentrations following the addition of TLR4-blocking antibodies, we hypothesized that TLR4 activity is required for microglial activation. Thus, we investigated whether selective knockdown of TLR4-receptor expression can similarly reduce the inflammatory status of microglia in our AD models. To test this, we used lentiviral particles to knock down TLR4 in wild-type (WT) microglial cells (TLR4-knockdown) and plated these cells in the angular chamber. TLR4-knockdown microglial cells exhibited a 79% decrease in TLR4 compared to WT microglial cells (Fig. 5g) . Knocking down TLR4 in microglial cells protected against neuron and astrocyte loss (2.3-fold) compared to WT microglial cells in the 3D Neu + AC + MG AD systems.
Human iPSC-derived AD Neu+AC replicate microglial recruitment, activation, and Neu+AC death in triculture. To confirm that the proposed mechanism can be replicated in other cultured human neurons/astrocytes, we newly generated human iPSC-derived neural stem cells (NSCs) expressing high levels of pathogenic Aβ species using techniques similar to those used for the ReNcell VM-based 3D AD models (Fig. 6a) . Human NSCs, stably expressing APPSL and GFP (AD iPSCs) or GFP alone (control iPSCs), were plated and differentiated for 3 weeks under 3D culture conditions. In these culture conditions, we also confirmed that cells were differentiated into neurons and astrocytes, respectively, as determined by the Tuj1,
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NATure NeurOscIeNce MAP2, and GFAP immunofluorescence staining (Fig. 6b,c) . To further examine the development of synapse-like structures, dendritic protrusions at week 0 and week 3 were compared (Fig. 6d,e) . In particular, we imaged these protrusions making connections between synapses-like structures in the volume (Fig. 6f) . As expected, the 3D Neu + AC + MG AD iPSC culture produced high levels of Aβ 40 (1.75 ng/mL) and Aβ 42 (0.45 ng/mL; Fig. 6g ). We also analyzed the cytokine secretion profile at week 3. Incubating 3D Neu + AC AD iPSC for 3 weeks led to increased cytokine and chemokine secretion. Indeed, the release of inflammation-related CCL2, CCL5, IL6, IL8, and MIF were upregulated following the addition of microglial cells (Fig. 6h) . Notably, IL-1β , IL-6, IL-10, and TNF-α were not detected in the 3D Neu + AC AD iPSC cultures without microglia (Fig. 6h) . Crucially, microglial migration and recruitment was largely elevated in the 3D Neu + AC + MG AD iPSCs as compared to in 3D Neu + AC + MG control iPSCs (Fig. 6i-j) . We next treated 3D Neu + AC + MG AD iPSC with IFN-γ and compared the neuron/astrocyte loss between AD and control cells. 3D Neu + AC + MG AD iPSCs showed substantially higher levels of neuron/astrocyte loss, while the IFN-γ -neutralizing antibody treatments protected against neuron/astrocyte loss (Fig. 6k,l) . These data further validated our findings on glial activation and the role of cytokines in 3D triculture models with iPSC-derived human neuron/astrocyte cells.
In conclusion, we were able to recapitulate dynamic neural-glial interactions in a 3D human triculture (Neu + AC + MG) system. This model was generated by differentiating genetically modified human NPCs into neurons and astrocytes, expressing AD pathological hallmarks: Aβ aggregation, p-tau formation, and chemokine and cytokines such as CCL2, TNF-α , and IFN-γ . We achieved this by co-culturing on a microfluidic platform and by triculturing human adult microglia in separated angular chambers to observe microglia recruitments with AD neuron and astrocytes. The relevance of this triculture model lies in the demonstration of physiologically relevant neural-glial interactions: microglial morphogenesis, recruitment, the release of proinflammatory cytokines and leukocyte 
NATure NeurOscIeNce chemokines regulated by AD neurons and astrocytes, and microglial neurotoxic activation contributing to neuron/astrocyte damage. These findings carry important implications for studies aimed at a deeper understanding of the gliosis and pathogenesis of AD and for screens aimed at finding new therapeutic molecules for preventing and treating AD.
Discussion
Relevant in vitro models of human AD brain must be capable of recapitulating all three pillars of AD pathology: Aβ accumulation, p-tau aggregation, and neuroinflammation. Human neurons derived from Alzheimer's disease patients have shown elevated levels of toxic Aβ species and phosphorylated tau. However, current AD neuronal models do not include neuroinflammatory changes that are mediated by microglial cells. To overcome this limitation, we developed a triculture system of neurons, astrocytes, and microglia that can achieve microglial recruitment, secretion of pro-inflammatory cytokines and chemokines, and neuron/astrocyte loss. The generation of this in vitro human AD culture model will provide more a physiologically relevant system to address key pathological features in AD.
Derived from 3D culture platforms, the microfluidic model presented a more physiologically relevant brain environment characterized by increased expression of neuronal (Tuj1, MAP2) and 
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NATure NeurOscIeNce astrocyte (GFAP) markers as compared to 2D systems, in agreement with previous reports 15 . Maturation of these neurons/astrocytes in 3D could result from several mechanisms: (i) materials whose properties closely mimic those of the in vivo extracellular matrix have been shown to promote differentiation of progenitor cells into the mature phenotypes 25 and/or (ii) the 3D environment provides a large surface area for growth and differentiation 26 . Notably, in contrast to previously developed AD-derived iPSCs that only showed 
NATure NeurOscIeNce early-stage AD signatures, at week 9 our 3D triculture model mimics late-stage AD markers, i.e., robust increases in p-tau formation. Moreover, the 3D triculture model secretes cytokines and chemokines such as TNF-α , IFN-γ , and MCP-1. The clinical relevance of these findings is supported by a marked upregulation of TNF-α in APP AD transgenic mice and by an increased expression of IFN-γ in AD brain tissue. IFN-γ is released predominantly by Aβ -activated immune cells 33, 34 and TNF-α -activated astrocytes [35] [36] [37] and binds to IFN-γ receptors, which are abundant and functionally present on microglia 38 . Taken together, these findings provide evidence that the combination of neurons, astrocytes, and microglia in 3D culture accelerates pathogenic cascades of AD, thus representing a suitable model for the study of AD mechanisms.
The role of chemokines in the recruitment of microglia in AD brain is not fully known. To identify the mechanism(s) of microglial accumulation into AD brain, we added adult microglia cells in a separate angular chamber connected to the precultured neuronal/ astrocyte central chamber. Microglial recruitment was substantially higher in the 3D Neu + AC + MG AD as compared to 3D control or 2D AD microenvironments. Although the higher recruitment in the 3D Neu + AC + MG AD neuron is likely due to a combination of many factors, three major elements contributed to the increase in microglia recruitment. First, Aβ accumulation affected the increase of microglia recruitment. In our previous study, we demonstrated that soluble Aβ served as a 'recruiting signal' for microglia 39 . 3D Neu + AC + MG AD was cultured for 9 weeks; thus, greater levels of Aβ were present in either 3D gel media or conditioned media. Second, 3D Neu + AC AD secreted key recruiting chemokines, such as CCL2/MCP-1, which is upregulated in human AD brains. CCL2/MCP-1 is produced mainly by cultured microglia 29 and astrocytes 40 . Indeed, neutralizing antibodies against CCL2/MCP-1 substantially inhibited the migration of microglia. CXCL10 induced migration and a proinflammatory phenotype in cultured microglia and T cells 41 . Finally, conditioned media from 6-and 9-week 3D Neu + AC + MG AD cultures showed increased adenosine triphosphate (ATP) levels, which likely promoted microglial activation or chemotaxis 42 . Microglia also express several purinoceptors, including a Gi-coupled subtype that has been implicated in ATPand adenosine diphosphate (ADP)-mediated migration in vitro 43 . An increase of extracellular ATP levels during AD progression has been reported in a murine model of the disease 44 . These data highlight the relevance of our 3D Neu + AC + MG AD neuron model for studying key factors driving microglia recruitment or for studying the expression of surface markers contributing to migration. Moreover, 3D Neu + AC AD-secreted Aβ and MCP-1 can both generate molecular gradients affecting microglial activation and alter their phenotype 39 . Changes in their phenotypes showed a trend for CD11b upregulation and correlated more closely with measures of the M1-like phenotype 45 . In addition to neurotoxic soluble factors, activated microglia have been shown to contribute to neuronal synapse engulfment by physical contact in AD mouse models, including C1q upregulation via the classical complement system 46 . In our 3D culture model, we observed physical interruptions between neurons and microglia, i.e., cleaved axons and retraction of neurite with co-localized microglia. While we could not determine whether microglia regulate synapses in our model, this observation demonstrated that our model will allow the study of neuronal loss associated with microglia physical interactions.
It should be noted that an immortalized microglia cell line, transformed with simian virus 40 (SV40) T antigen, was used in our studies. Extending these studies using human iPSC-derived microglia as well as primary microglia will be helpful to confirm our findings. Future studies incorporating AD-risk-associated innate immune genotypes, for example, CD33 and TREM2, in 3D mixed neural-glial cultures should be another application.
In conclusion, our 3D AD culture model represents a substantial improvement over current in vitro human AD models by adding inflammatory activity. Although physiologically relevant in vivo studies will ultimately be needed to confirm the clinical utility of our model, success of this 3D triculture modeling should foster a greater understanding of the molecular mechanisms underlying gliosis and pathogenesis, as well as more effective screening for therapies aimed at slowing, stopping, or reversing neurodegeneration in AD.
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Statistical Data was analyzed with Graphpad 6. Surface area was analyzed based on "Area Measurements of a Complex Object" which is sharing resource and can be found on website. (https://imagej.nih.gov/ij/docs/pdfs/examples.pdf) Cell counts by using CellProfiler was followed by the protocol on the website (http://cellprofiler.org/tutorials/). Specific settings of cell counts are in below: Nuclei, Typical diameter of objects: 8,20, Threshold correction factor: 1.2, Lower and upper bounds on threshold 0.04, 1.0
For manuscripts utilizing custom algorithms or software that are central to the research but not yet described in published literature, software must be made available to editors/reviewers upon request. We strongly encourage code deposition in a community repository (e.g. GitHub). See the Nature Research guidelines for submitting code & software for further information. All studies must disclose on these points even when the disclosure is negative.
Sample size no sample sizes were predetermined with statistical methods. but our sample sizes are similar to those generally employed in the field. At least 3 devices were used in each group. Our sample sizes were sufficient to detect differences among samples Data exclusions Exclusion criteria for experimental data points were death of cells cause of contamination during the experimental period. No outliers were excluded in this manuscript.
Replication
For each experimental condition, at least 3 sections were analyzed per conditions and at least 3 devices were used per conditions. All attempts at replication were successful expect for the failures due to sickness or death of animals during the experimental period.
Randomization Blocking antibodies were randomly administered to AD neuron/astrocyte/microglia tri-culture models at different weeks
Blinding
Data collections were performed together in shared microscope and the blind analysis to the conditions were performed for the each experiments.
Reporting for specific materials, systems and methods 
